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Abstract
Self-assembled peptide nanofibers form three-dimensional networks that are quite similar to fibrous
extracellular matrix (ECM) in their physical structure. By incorporating short peptide sequences derived
from ECM proteins, these nanofibers provide bioactive platforms for cell culture studies. This protocol
provides information about preparation and characterization of self-assembled peptide nanofiber scaffolds,
culturing of neural stem cells (NSCs) on these scaffolds, and analysis of cell behavior. As cell behavior
analyses, viability and proliferation of NSCs as well as investigation of differentiation by immunocytochem-
istry, qRT-PCR, western blot, and morphological analysis on ECMmimetic peptide nanofiber scaffolds are
described.
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1 Introduction
Neural stem cells (NSCs) are the stem cells of the central nervous
system (CNS), which are present in both embryonic and adult
brain. In contrary to other neural cells of CNS, NSCs have prolif-
erative ability. They demonstrate not only self-renewing ability but
also potential to differentiate into neurons, astrocytes, and oligo-
dendrocytes (1). However, NSCs are very low in number and are
localized to very restricted areas in brain (such as dentate gyrus and
subventricular zone in adult human brain), which make them
insufficient to regenerate the brain after any neural degeneration.
Transplantation of either NSCs or differentiated cells from NSCs is
considered to be a promising approach for CNS regeneration (2).
Obtaining NSCs for such a therapy has been the pitfall of this
approach as they can only be obtained from adult cadavers or
aborted fetuses, both of which can be considered as allotransplants
bearing risk of immune rejection. In addition, use of fetal cells raises
ethical concerns about such a therapy. Fortunately, iPSC-derived
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NSCs have recently been introduced, solving both the donor
shortage problem and immune rejection risk, as they are the own
cells of the patient (3). They have been proved to have similar self-
renewal and differentiation capacity to the NSCs isolated fromCNS
(4). Besides, generation of NSCs directly from fibroblasts is also
found to be possible by skipping the iPSC step. These cells are even
safer for clinical use as they are proved to have no teratogenic risk
upon transplantation (5, 6).
Although it is promising to transplant NSCs to the damaged
area of the brain, it is not as successful as desired when used alone.
This is mainly due to the non-permissive environment in the degen-
erated area which inhibits regeneration (7). Hence, transplantation
within a permissive scaffold, which supports adhesion and prolifer-
ation of NSCs or axonal extension by neurons differentiated from
NSCs, would be a better alternative to transplanting NSCs alone.
Self-assembled peptide nanofibers are powerful tools for pro-
ducing bioactive scaffolds that are tailored according to the
demands of the specific cells. Peptide amphiphiles (PA), which are
molecules consisting of a hydrophobic alkyl chain conjugated to a
peptide sequence, can be used as building blocks of these scaffolds.
Peptide part of the PA molecules usually contains an amino acid
sequence containing β-sheet-prone amino acids such as valine or
alanine along with some charged amino acids and an epitope
sequence for bioactivity (8). Charged amino acids are important
both for solubility of the peptide and for nanofiber formation. PA
molecules of opposite charges come together by electrostatic inter-
actions in aqueous environment along with the hydrophobic inter-
actions of alkyl groups. Through these interactions, peptide
nanofibers, that are 8–10 nm in diameter, are produced. These
nanofibers are actually cylindrical micelles where hydrophobic tails
are embedded in the nanofibers and hydrophilic peptide sequences
containing the epitope remain on the periphery of the nanofibers.
During formation of the nanofibers, water is trapped in the peptide
nanofiber networks leading to formation of a hydrogel system.
Physical structures of these nanofiber networks are quite similar
to the structure of fibrous extracellular matrix (9, 10). Besides
having similar structure to ECM, these scaffolds can be produced
with similar bioactivity by incorporating short peptide sequences in
the epitope region, which are derived from the cell surface receptor
interacting domains of ECM proteins. RGDS (11), KRSR (12),
YIGSR (13), DGEA (12), REDV (14), and IKVAV (9, 15) are
some of these sequences that have been previously used to obtain
bioactive peptide nanofiber scaffolds. IKVAV is a peptide sequence
derived from laminin, and incorporation of this sequence in peptide
nanofiber scaffolds has been shown to direct NSC differentiation
into neurons rather than astrocytes or oligodendrocytes (15).
In this chapter, production of peptide nanofiber scaffolds from
peptide amphiphilemolecules, their characterization, andutilization
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for NSC culture and differentiation are described. Protocols for
analyzing the effect of the scaffold onNSCviability and proliferation
as well as analysis of the scaffold effect on differentiation are
provided. Immunostaining of cell type-specific proteins along with
qRT-PCR and western blot analysis is explained in detail. In addi-
tion, a method for quantitative analysis of morphological changes
after differentiation is provided.
2 Materials
2.1 Cell Culture 1. Serological pipettes (Axygen), 15 and 50 mL conical tubes
(CAPP), sterile pipette tips (filtered tips are preferred, Expel),
tissue culture flasks and plates (Corning).
2. NSC culture medium: KnockOut DMEM/F-12 medium sup-
plemented with 1 % GlutaMAX-I, 2 % StemPro NSC SFM
Supplement, 20 ng/mL bFGF and EGF (all from Invitrogen).
It is stable for 4 weeks when stored in the dark at 4 C. Prepare
100 mL each time, and work in aliquots to avoid exposing it to
37 C multiple times.
3. NSC differentiation medium: Same with NSC culture medium
except that it is not supplemented with bFGF and EGF.




1. Alamar Blue reagent (Invitrogen).
2. Live/Dead Assay (Invitrogen).
3. Cell proliferation ELISA, Colorimetric BrdU assay (Roche).
2.3 Immunocyto-
chemistry
1. 13 mm diameter, round glass coverslips (Thermo Scientific).
2. 4 % paraformaldehyde (PFA) solution (16): Add 4 g PFA (see
Note 1), 4 g sucrose, 10 mL 10 PBS, 0.5 mL 1 M MgCl2,
2 mL 0.5 M EGTA into 75 mL ddH2O and mix on a magnetic
stirrer. Add 10 N NaOH dropwise until solution clears. Then,
adjust pH to 7.4 by dropwise addition of 6 N HCl, and adjust
volume to 100 mL by adding ddH2O. Aliquoted solution can
be stored at 20 C until use. Heat is not preferred for dissol-
ving PFA since higher temperatures can lead to generation of
formic acid which results in increased background staining.
Instead, pH transition is used to dissolve PFA in this protocol.
MgCl2 along with EGTA is used to preserve cytoskeletal struc-
ture, and sucrose is used to maintain overall morphology dur-
ing fixation.
3. 0.3 % TritonX solution: Dissolve TritonX detergent in PBS to a
final concentration of 0.3 % (v/v) on a magnetic stirrer until
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you obtain a homogeneous solution. Solution can be stored at
room temperature (RT).
4. Blocking solution: Prepare by adding 1 % BSA (diluted from a
10 % stock in PBS) and 10 % normal goat serum into 0.3 %
TritonX solution. This solution is prone to contamination; thus
prepare it fresh. 10 % BSA solution along with goat serum are
stored at 20 C in 1 mL aliquots.
5. Primary antibody dilution solution: Prepare similarly to
blocking solution except that final concentration of normal
goat serum here is 3 %.
6. Secondary antibody dilution solution: Dilute 10 % BSA stock
solution to a final concentration of 1 % in PBS.
7. TO-PRO-3 (Invitrogen) diluted solution: Dilute 1 mM stock
solution to 1 μM final concentration in PBS.







5. DNase/RNase free water (Gibco).
6. DNase/RNase-free microcentrifuge tubes and pipette tips.
7. Temperature-controlled centrifuge.
8. Primer sets for target genes and at least one housekeeping gene.
9. SuperScript®III Platinum® SYBR®Green One-Step qRT-PCR
Kit (Invitrogen).





1. Lysis buffer: Prepare a 4 stock without protease inhibitor (PI)
cocktail. Dilute to 1 with ddH2O, and add PI at a final
concentration of 2 % immediately before use. Prepare 4 lysis
buffer by mixing 2 mL of 1 M Tris–HCl, pH 6.8 (final concen-
tration: 200 mM), 160 μL of 0.5 M EDTA, pH 8.0 (final
concentration: 8 mM), 4 mL of 10 % SDS (final concentration:
4 %), 400 μL β-mercaptoethanol (final concentration: 4 %), and
3.2 mL of glycerol (final concentration: 32 %). Adjust volume
to 10 mL by adding ddH2O. Mix by vortexing. Aliquot the 4
lysis buffer, and store at 20 C until use.
2. Novex bis–tris 4–12 % acrylamide gels (Invitrogen).
3. Reagents and protein standards for Bradford protein assay
(BioRad).
4. PVDF membrane (Thermo Scientific).
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5. Filter papers for blotting (BioRad).
6. Semi-dry blotting system (BioRad).
7. Anode I buffer: 0.3 M Tris–HCl (pH 10.4), 10 % methanol.
8. Anode II buffer: 25 mM Tris–HCl (pH 10.4), 10 % methanol.
9. Cathode buffer: 25 mM Tris–HCl (pH 9.4), 10 % methanol,
40 mM glycine
10. Blocking solution: Dissolve nonfat dry milk (5 wt%) in new
TBS buffer, and add 0.1 % (v/v) Tween 20. Mix on a magnetic
stirrer until a homogeneous solution is obtained.
11. Tris-buffered saline (TBS): Prepare 10 TBS by mixing
200 mL of 1 M Tris–HCl, pH 7.5 (final concentration:
200 mM) and 292.2 g NaCl (final concentration: 5 M) on a
magnetic stirrer. Adjust volume to 1 L by adding ddH2O.
Dilute to 1 with ddH2O. Both 10 and 1 buffers can be
stored at room temperature.
12. TTBS: Prepare by mixing 100mL 10TBS, 0.5 mLTween-20
(final concentration: 0.05 %), and 900 mL ddH2O. It can be
stored at room temperature.
13. New TBS: Prepare by mixing 10 mL of 1 M Tris–HCl, pH 7.5
(final concentration: 0.01 M), 30 mL of 5 M NaCl (final
concentration: 0.15 M), and 960 mL of ddH2O. It can be
stored at room temperature.
14. Novex Chemiluminescent Substrate (Invitrogen).
15. BioRad Imaging Station.
16. UREA buffer: 0.1MNa2HPO4, 0.01MTris–HCl, 8M urea in






Peptides are synthesized by a standard Fmoc-protected solid-phase
peptide synthesis method. Synthesis, purification by high-
performance liquid chromatography (HPLC), and characterization
methods were previously described in detail (8).
1. After reverse-phase-high-performance liquid chromatography
(RP-HPLC) purification of the peptide, evaporate acetonitrile
by rotary evaporation and freeze-dry the peptide to obtain it in
powder form.
2. Dissolve the peptide in desired concentration in ddH2O. Mix
by vortexing, and sonicate in ultrasound water bath until it
completely dissolves. Check the pH of the peptide solution by
using pH paper. Adjust the pH to 7 with NaOH or HCl
solutions.
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3. In order to analyze hydrogen bonding interactions, carry out
circular dichroism (CD) measurements. Dissolve peptides to
2.5  10-4M concentration as described above.Mix oppositely
charged peptides in desired proportions, and mix by pipetting.
Do not vortex in order not to disrupt the de novo-formed
secondary structures. Detailed protocols are described here (8).
4. Stiffness of scaffold is an important physical property affecting
the behavior of neural cells (17). In order to measure the
stiffness of peptide nanofiber scaffolds, carry out rheological
measurements. Prepare peptide gels of intended concentrations
at a volume sufficient to fill the area of the upper plate. Prepare
the gel on the lower plate, and incubate for at least for 10 min
for gelation before measurement. Perform frequency sweep to
determine storage modulus (G0) and loss modulus (G00). The
G0 value being higher than G00 value indicates the gel behavior
of the scaffold prepared. More detailed protocols for rheologi-
cal analysis of peptide gels can be found here (8).
5. Characterize morphology of peptide nanofiber networks and
peptide nanofibers individually by SEM and TEM imaging,
respectively (Fig. 1). SEM imaging reveals the overall morphol-
ogy of the scaffolds, while TEM is informative for investigating
the morphology of individual fibers. It is possible to determine
the diameter of peptide nanofibers from images taken by TEM.
Detailed protocols of sample preparation and imaging para-
meters are explained here (8, 18).
3.2 Preparation
of Scaffolds and NSC
Culture
Peptide nanofiber scaffolds at physiological pH are produced by
mixing oppositely charged peptide molecules dissolved in ddH2O.
Peptide nanofibers are formed by electrostatic interactions of
Fig. 1 (a) SEM image of the peptide nanofiber network, (b) TEM image showing individual peptide nanofibers
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oppositely charged side chains as well as hydrophobic interactions
of the alkyl groups. By entrapment of water in between nanofiber
networks during gelation, hydrogel scaffolds are produced.
1. Dissolve peptide powders in sterile ddH2O at intended con-
centrations (usually 0.1–1 wt%, see Note 2). Adjust pH to 7.4
as explained in Section 3.1, and sonicate in ultrasound water
bath until they completely dissolve. UV sterilize peptide solu-
tions for at least 30 min.
2. For peptide nanofiber gel formation, add one of the oppositely
charged peptide solutions to the well and then add the second
solution via mixing with the pipette tip (with a swirling
motion). A total volume of 300 μL is enough for 24-well
plate wells. You can adjust the volume for larger or smaller
surfaces accordingly. While preparing gels, consider the final
charge of the scaffold and mix two peptides in proper ratios
accordingly. An optimization for the charge might be required
to obtain optimal bioactivity of the scaffold.
3. After coating of wells with peptide gels, incubate the plate at
37 C for 30 min to 1 h for gelation to proceed and dry
overnight under sterile conditions in a laminar flow hood.
This step is carried out to evaporate water in the scaffold and
obtain a nanofibrous network coating of the culture well sur-
face. This network swells again with the culture medium and
forms a very thin layer of gel beneath cells.
4. UV sterilize the peptide nanofiber-coated plate for at least 1 h.
5. Seed NSCs at a density of 5  104 cells/cm2 in 500 μL/well
for 24-well plate (see Note 3). You can adjust the volume for
larger or smaller surfaces accordingly. After seeding, gently
swirl the plate with your hand to obtain a homogeneous distri-
bution of cells. Note that this protocol describes adherent
culture of NSCs, not suspension culture as in the form of
neurospheres. Incubate the plate at 37 C, 5 % CO2 in a
humidified incubator. Change medium every 3 days.
3.3 Analysis of NSC
Behavior on Scaffolds
3.3.1 Viability
Viability of the cells can be determined by either Alamar Blue Test or
Live/Dead Assay as described below. Both detect live cells through
metabolic activity of live cells, while Live/Dead Assay also detects
dead cells by plasma membrane disintegrity. Detecting dead cells
along with live cells is advantageous in that it directly provides data
related to any cytotoxic effect leading to cell death. When the
number of living cells is observed to be reduced by Alamar Blue,
where only live cells are detected, it is not easy to understand if such a
drop is caused by decreased cell proliferation or cell death. Detect-
ing dead cells at the same time becomes advantageous in such a case.
Alamar Blue Test Alamar Blue (AB) Test is a metabolic activity-based viability test.
Active ingredient of AB reagent is resazurin, which is blue in color
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and non-fluorescent. Resazurin can readily enter into cells (it is cell
permeable), and upon entering, it is reduced to resorufin by active
metabolism of live cells. Resorufin is pink and fluorescent. The
amount of resorufin produced and absorbance/fluorescence
measured are directly proportional to the number of living cells.
1. Coat the wells of a 96-well plate with peptide nanofibers as
described in Section 3.2. Prepare peptide nanofiber-coated
wells to be used as blank as well. This is to avoid any back-
ground absorbance that might be caused by peptide
nanofibers.
2. Seed cells at a density of 5  103 to 2  104 cells/well
depending on the incubation time prior to viability measure-
ment. Too low cell density leads to insufficient color develop-
ment leading to unreliable results, while too high cell density
leads to contact inhibition as well as cell death which again
results in unreliable data. Add medium without cells to wells
that will be used as blank.
3. At the time of analysis (usually in between 24 and 72 h), discard
medium from wells and add 110 μL of fresh medium with
Alamar Blue reagent (100 μL medium+10 μL AB/well).
10 μL of AB can also be added directly to medium over cells
without discarding the medium, but in the case of long culture
periods, non-even evaporation from wells might lead to some
inconsistency. Hence, it is better to discard all medium and add
same amount to all wells. This step should be carried out at
dark (see Note 4).
4. Incubate the plate in a CO2 incubator (37
C, 5 % CO2) for
2–4 h, depending on cell density. Color change from blue to
pink can be tracked to determine the time of measurement.
5. Measure absorbance at 570 nm (reference λ: 600 nm). Alterna-
tively, fluorescence can also be measured (excitation: 560 nm,
emission: 590 nm).
Live–Dead Assay Live–Dead Assay is a viability test which is used to detect live cells as
well as dead cells. This assay is based on esterase activity of live cells
and loss of plasma membrane integrity of dead cells. Calcein AM is a
cell-permeant, non-fluorescentmolecule which is cleaved by intracel-
lular esterases upon entering cells. Calcein formed after esterase
cleavage is well retained in live cells (it is cell impermeant) and gives
an intense green fluorescence by which live cells can be detected.
Dead cells are distinguished by ethidium homodimer staining. Ethi-
dium is excluded by plasmamembrane in live cells, while it is retained
in dead cells due to disintegrity of plasma membrane. Dead cells can
be detected by red fluorescence of ethidium homodimer dye.
1. Coat the wells of a 96-well plate with peptide nanofibers as
described in Section 3.2.
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2. Seed cells at a density of 5  103 to 2  104 cells/well
depending on the time at which viability will be determined.
Too low density leads to insufficient cell number in images
leading to statistically unreliable results, while too high cell
density leads to difficulties in distinguishing cell borders
which again results in unreliable data.
3. At the time of analysis (usually in between 24 and 72 h),
centrifuge the plate at 650  g for 5 min in a centrifuge with
a plate rotor. This step is essential to detect dead cells that
usually detach and float in the medium. If not centrifuged,
they will be discarded in the next step and will not be detected.
4. During centrifugation, prepare calcein + ethidium working
solution by diluting calcein and ethidium to a final concentra-
tion of 2 and 4 μM, respectively, in PBS. Since 200 μL/well will
be used, prepare total volume according to the number of wells
in the experiment. This step should be carried out in the dark to
avoid fading of ethidium dye.
5. After centrifugation, discard medium over cells and add PBS
slowly avoiding to detach cells. Carry out a brief (1–2 min)
centrifugation at 650  g. PBS wash is carried out to remove
any serum esterase that cleaves calcein and leads to nonspecific
background fluorescence.
6. After PBS wash, add 200 μL/well calcein+ethidium working
solution (prepared in step 4) and incubate the plate for 30 min
at room temperature (RT) in the dark.
7. After incubation, take merged images of calcein-stained live
cells (green) and ethidium-stained dead cells (red) immediately
by using an inverted fluorescent microscope. Take at least five
random images/well.
8. Count the number of live and dead cells with Image J (Plugin:
Cell Counter). Determine the % of live and dead cells on each
substrate. Fluorescence of ethidium and calcein can also be
measured alternatively as described in the product’s manual.
However, ethidium nonspecifically adheres to peptide nanofi-
bers and produces high background due to which fluorescence
measurement is not preferred. Dead cells are stained more
intensely than the background and can be distinguished in
images taken for counting.
3.3.2 Proliferation Test
(BrdU Assay)
Stem cells, including NSCs, proliferate in culture. NSCs differenti-
ate into neurons, astrocytes, or oligodendrocytes which are all
nonproliferating cells. Hence, upon induction of differentiation a
reduction in proliferation might indicate differentiation. However,
this should not be used as the only data for verification of differen-
tiation, since NSCs can also lose their proliferative ability due to cell
senescence at later passage numbers. BrdU assay is commonly used
for detection of proliferation. BrdU is a thymine analog, and it is
incorporated into newly synthesized DNA in dividing cells; BrdU
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levels measured by ELISA are directly proportional to the number
of proliferating cells.
1. Coat the wells of a 96-well plate with peptide nanofibers as
described in Section 3.2. Prepare peptide nanofiber-coated
wells to be used as blank as well. This is to avoid any back-
ground absorbance that might be caused by peptide
nanofibers.
2. Seed cells at a density of 5  103 to 2  104 cells/well
depending on the time at which proliferation will be deter-
mined. Too low density leads to insufficient color development
leading to unreliable results, while too high cell density leads to
contact inhibition as well as cell death which again results in
unreliable data. Add medium without cells to wells that will be
used as blank.
3. 2–24 h (depending on cell density and doubling time of cells)
prior to the detection, discard medium over cells and add
100 μL of fresh medium with 10 μM BrdU reagent. 10 μL of
BrdU from stock can also be added directly to medium over
cells without discarding the medium, but in case of long culture
periods, non-even evaporation from wells might lead to some
inconsistency. Hence it is better to discard all medium and add
same amount to all wells. Incubate cells under standard cell
culture conditions until the analysis (2–24 h later).
4. Discard the medium over cells by tapping or suction. The assay
can be interrupted at this step to continue later. Dried cells can
be stored for up to 1 week at 2–8 C until analysis.
5. Fix cells by adding 200 μL/well fixation solution provided in
the kit, and incubate for 30 min at RT.
6. Remove fixation solution by flicking off and tapping. Add
100 μL/well peroxidase-labelled BrdU antibody working solu-
tion (1:100 diluted from stock), and incubate for 90 min at RT.
7. Discard antibody solution by flicking off, and rinse wells with
200 μL/well PBS three times.
8. Discard PBS by tapping, and add 100 μL/well peroxidase
substrate. Incubate at RT until color development is sufficient
for detection (5–30 min). Measure absorbance at 372 nm (ref-
erence λ: 492 nm). Repeated measurements can be done in





Forty-eight hours after seeding cells on peptide nanofiber scaffolds
in NSC culture medium, discard the medium over cells and add
NSC differentiation medium. Note that this medium is suitable for
spontaneous differentiation of NSCs into neurons, astrocytes, and
oligodendrocytes. Such an experiment is useful to determine the
effect of the scaffold bioactivity in cell fate. If differentiation into a
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specific cell type is desired, additional growth factors should be
included in the differentiation medium.
3.4.1 Immunocyto-
chemistry
Immunostaining against specific markers of NSCs, neurons, astro-
cytes, and oligodendrocytes is a powerful method in analysis of
spontaneous differentiation as it allows to determine which cell
fate is more dominantly directed by the scaffold. Most commonly
used markers for this analysis are shown in Table 1.
1. For immunostaining, coat peptide nanofibers on 13 mm glass
slides placed in 24-well plates, and culture and differentiate
NSCs on these surfaces.
2. At the intended time point for analysis, discard the medium
over cells and wash wells with PBS (750 μL/well). Be careful
not to detach cells in this step.
3. Fix cells with prewarmed 4 % paraformaldehyde, 500 μL/well
for 15 min at RT.
4. Permeabilize cells with 500 μL/well 0.3 % TritonX for 15 min
at RT. Slowly mix on shaker.
5. Wash with 750 μL/well PBS for 5 min three times on shaker.
6. Add 500 μL/well blocking solution, and incubate for 1 h at
RT. Slowly mix on shaker.
7. Add 100 μL/well diluted primary antibody (see Note 5 for
co-staining), seal the plate with parafilm, and incubate over-
night at 4 C on a shaker at slow rate (a nutator/rocking shaker
is preferred). Next day, continue with an additional 30-min to
1-h incubation at RTon shaker. For samples that will be used as
negative control of staining, add primary antibody dilution
solution described in Section 2.3 instead of primary antibody.
8. Wash with 750 μL/well 0.3 % TritonX for 5 min on shaker.
9. Wash with 750 μL/well PBS for 5 min on shaker.
10. Add 100 μL/well diluted secondary antibody that is conjugated
with a fluorescent dye for detection. Incubate for 1 h at RTon a
shaker at slow rate (a nutator/rocking shaker is preferred).
Table 1
Markers commonly used for analysis of cell fate after NSC differentiation
Cell type Markers Reference
NSC Nestin (19)
Neuron Map2, β-III-tubulin (20–22)
Astrocyte GFAP (23)
Oligodendrocyte GalC (24)
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Starting from this step work in the dark in order to avoid fading
of fluorescence.
11. For nuclear staining, add 300 μL/well TO-PRO-3 (1 μM final
concentration) and incubate at RT for 15 min (see Note 6 for
other nuclear staining options).
12. Wash with 750 μL/well PBS for 5 min three times on shaker.
13. Wash with 750 μL/well ddH2O for 5 min on shaker. This step
is essential to avoid salt crystals that form during drying due to
the remaining PBS.
14. Label slides properly, and add one drop of ProLong Gold
Antifade Mounting Medium onto each slide avoiding bubbles.
15. Remove cover slip from well, invert, and put on the mounting
solution on the slide. Avoid making air bubbles during this
step.
16. Let the cover slip dry, and seal the edges with nail polish. Slides
can be stored in the dark at 4 C for at least a couple of months.




All plastic materials and solutions used should be RNase free, and
experiments should be carried out under class I laminar flow hood.
RNA Isolation RNA isolation from low cell numbers is not efficient, so it is better
to carry out differentiation in 6-well plates for this experiment. Use
cold reagents (stored at 4 C), and carry out centrifugation steps at
4 C in order to avoid RNA degradation.
1. Discard medium from wells, and add 1 mL/well TRIzol. Carry
out this step in a fume hood as TRIzol is toxic. Swirl the plate
for efficient distribution of TRIzol through wells, and collect
cell lysates in 1.5 mL labelled microcentrifuge tubes. After this
step, samples can be stored at 80 C until RNA isolation.
2. Add 200 μL/tube chloroform, shake tubes vigorously for 15 s,
and incubate for 2–3 min at RT.
3. Centrifuge samples at 21,500  g for 17 min. After centrifu-
gation, three layers with pink, white, and clear colors appear
from the bottom to top. Transfer 500 μL of the upper (clear)
phase into a new tube for each sample trying not to disturb
bottom layers.
4. Add 500 μL/tube isopropanol, and mix by inversion 15 times.
Incubate for 10 min at RT.
5. Centrifuge samples at 6,100  g for 12 min. Discard superna-
tant, and add 1 mL of 75 % EtOH. Do not dissolve the pellet;
just detach it from the tube wall.
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6. Centrifuge samples at 6,100  g for 8 min. Discard
supernatant, and add 1 mL pure EtOH. Do not dissolve the
pellet; just detach it from the tube wall.
7. Centrifuge samples at 6,100  g for 8 min. Discard superna-
tant, and air-dry pellets for 3–5 min. Do not overdry as it
reduces solubility of RNA in water. Add 30 μL/tube DNase/
RNase-free water, and dissolve the pellet by pipetting.
8. Measure RNA concentration and absorbance ratios of 260/
280 and 260/230 nm at Nanodrop. 260/280 ratios of
1.9–2.1 and 260/230 ratios of 2–2.3 are acceptable for use
of RNA in qRT-PCR. Isolated RNA should be stored at
80 C until use.
qRT-PCR For analysis of expression of marker genes, Pfaffl method is used for
analysis of qRT-PCR results where primer efficiencies are also con-
sidered. We carry out cDNA synthesis and amplification of cDNAs
in one reaction by using SuperScript®III Platinum® SYBR®Gree-
nOne-Step qRT-PCR Kit (Invitrogen), which is a conventional and
time saving method. The below protocol is for the use of this
method.
1. Design primers specific for the target genes. Try to select
primers from exon–exon boundaries so that the DNA cannot
be amplified (due to the long intron sequence involved, which
is not present in RNA). If not possible, DNase treatment
should be carried out to avoid amplification of DNA besides
RNA.
2. Before expression analysis, optimize annealing temperature for
primers. After that, determine primer efficiency by carrying out
qRT-PCR with serial dilutions of RNA. Plot a standard curve
with the Ct values (y-axis) and RNA concentrations (x-axis),
and determine the slope of the curve. Efficiency should be in
the range of 90–110 % for reliable PCR results. Efficiency (E)
can be calculated by using the formula E ¼ 10(1/slope)  1.
3. Carry out qRT-PCR using primers for target genes as well as
those for housekeeping genes. From Ct values obtained, per-
form a gene expression analysis by normalizing the results to
those of housekeeping genes. You can now compare the expres-




In order to obtain enough protein amount in cell lysate, using high
cell numbers (at least 1.5–2  105 cells) is essential. Hence, it is
better to carry out differentiation in 6-well plates for this experi-
ment.During cell lysate preparation from cells cultured on uncoated
surfaces, adding lysis buffer directly to the well and scraping is a
conventional method. However, for peptide nanofiber-coated sur-
faces, this method is not suitable as peptide scaffold is also collected
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and contributes to the protein amount detected during protein
assay. This leads to confusion in understanding the total protein
amount obtained from cells. For this reason, prefer to detach cells
enzymatically and lyse them later. For blotting, we prefer to use
semidry blotting by using Bio-Rad’s equipment, and the below
protocol is optimized for this method.
1. Detach cells by using conventional trypsin detachment
method. Since cells might adhere to peptide scaffolds very
strongly, they might not detach with only trypsin treatment.
If you have problems in detaching cells by this method, you can
try 1:1 mixture of trypsin (0.25 % trypsin–EDTA):collagenase
(1 %). Incubate cells with this mixture for 30 min at 37 C, and
observe every 10 min under microscope after tapping to help in
detachment. Almost 90 % of cells detach with this method from
the surfaces where cells adhere very strongly.
2. After detaching cells, centrifuge at 650  g for 5 min to obtain
cell pellet. Dissolve the pellet in PBS, and centrifuge again.
3. Discard the PBS, and resuspend the pellet in 50–100 μL lysis
buffer depending on the pellet size (see Section 2.5).
4. Incubate samples on ice for 30 min. Vortex every 10 min.
5. Sonicate samples on ice with a probe sonicator for 15–30 s.
6. Heat samples to 95 C for 5 min, and cool on ice. This step is
essential to denature DNA, which causes viscosity in samples.
Samples can be stored at 80 C after this step until use.
7. Determine the total protein amount in cell lysates by a method
of your choice. We use Bradford Assay in our laboratory. Take
care that the assay you choose does not interfere with the
components of the lysis buffer and give false-positive results.
8. Load samples (30–100 μg) and molecular weight marker to
4–12 % commercial gels for SDS-PAGE, and run the gel
according to the manual provided with the gel. In order to
check that blotting occurs properly and your antibodies work
perfectly, you can load a positive control to one of the wells.
Brain lysate can be used for this purpose as it contains all the
neural marker proteins (see Note 7 for preparation of brain
lysate).
9. For blotting, cut the PVDF membrane and extra thick filter
papers to the dimensions of the gel. Three pieces of filter papers
are required for one gel.
10. Equilibrate the gel and membrane in ice-cold transfer buffers
(see Section 2.5) as described in Table 2.
11. Assemble the blotting unit, and place the filter papers, gel, and
membrane according to Table 2. The filter paper which was wet
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with cathode buffer will be at the top. Roll out air bubbles at
every layer by using a glass pipette.
12. Carry out blotting at 14 V for 30 min.
13. After blotting, place the membrane in blocking solution (see
Section 2.5) and incubate for 2 h at RT, shaking slowly.
14. Discard blocking solution, and add primary antibody diluted in
blocking solution. Incubate overnight at 4 C, shaking slowly.
Next day, incubate at RT for 30 min to 1 h.
15. Wash with blocking solution for 20 min at RT with shaking.
16. Add secondary antibody diluted in blocking solution. Incubate
for 45 min at RT, shaking slowly.
17. Wash membrane with TTBS for 5 min twice and TBS for 5 min
twice, with shaking.
18. Wash membrane with ddH2O for 5 min.
19. Prepare substrate (Novex Chemiluminescent Substrate) imme-
diately before use by mixing Reagent A and Reagent B in 1:1
ratio. It is essential to warm substrate reagents to RT before
use. Work in a darkroom from this point forward.
20. Add substrate on the membrane, and incubate for 1 min. Use
substrate volume enough to cover the surface of the
membrane.
21. Image the membrane with BioRad imaging station, VersaDoc
software by selecting Blotting, “Chemiluminescence, Ultra-
High Sensitivity” from the software with 600 s exposure time.
3.4.4 Analysis of Neurite
Outgrowth
Neurite outgrowth is an indication of neuron’s response to axon
guidance cues provided by the environment and hence an important
indication of the bioactivity of the scaffold used in directing NSCs
towards differentiation. Analysis of neurite outgrowth by ImageJ
Table 2
Equilibration of filter papers, gel, and membrane before blotting
Layer starting
from the bottom Material Equilibration
1 Filter paper Wet with anode buffer I
2 Filter paper Wet with anode buffer II
3 PVDF
membrane
15 min with methanol, 2 min
with ddH2O, 5 min with
anode II on shaker
4 Gel 15 min with anode II
5 Filter paper Wet with cathode buffer
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program is described in this section. ImageJ is an NIH-released free
program that can be downloaded from http://rsbweb.nih.gov/ij/.
1. At the intended time of analysis (multiple time points during
differentiation is useful), take at least five random images from
each sample. You should study with at least three replicates (n)
within each experimental group.
2. Open the image to be analyzed with ImageJ program. Select
segmented line in the tabs which allows to track neurites even
when they are curved. From shortcuts list, find the shortcut for
“Measure and Label.” This shortcut is a letter in the keyboard
which you can use to measure the length of the neurite you
tracked. Besides it labels the track so that you do not measure it
twice. After labeling and measuring all neurites in the image
you can transfer results to Excel for further analysis such as the
total neurite length in the image. Besides, by using the cell
counter plug-in, you can count the total number of cells in the
image as well as the cells extending neurites.
3. After measuring the total neurite length, total number of cells,
and number of cells extending neurites, you can now calculate
the average neurite length in that image as well as % of cells
extending neurites. Note that the length measured in ImageJ is
in arbitrary unit (au). You can convert this to μm by measuring
the scale bar in the image and finding the conversion factor
between au and μm. By using this conversion factor, you can
now express the average neurite length in the image in μm
scale.
4. After completing the measurement of all images, take average
of random images from the same well and after that take
average of different samples of the same experimental group
and find the standard deviation within the group.
4 Notes
1. PFA is toxic; weigh and prepare the solution in a fume hood.
2. Gelation properties and bioactivity of different peptides might
differ. Hence, it is better to carry out an optimization with
different concentrations of peptides for scaffold preparation.
Lower concentrations might not lead to gel formation, while
too high concentrations result in opaque gels leading to diffi-
culty in observing cells under optical microscope. Besides, the
concentration with optimal bioactivity should be determined
with such an optimization assay.
3. We use rat fetal NSCs obtained from Invitrogen. These cells are
isolated from cortex of embryonic day 14 Sprague–Dawley
rats. Seeding density of 5  104 cells/cm2 is suggested for
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these cells to avoid spontaneous differentiation. If using cells
from other sources, it is better to optimize seeding density
prior to other experiments.
4. Avoid exposing Alamar Blue reagent to light as it is reduced in
light which leads to false-positive results.
5. Co-staining of different proteins in same samples is a powerful
method for determining % of different cell types in the same
population of cells. In order to carry out co-staining, you need
to select primary antibodies from different sources (such as one
from mouse, the other from rabbit) and secondary antibodies
specific to these primary antibodies should be labelled with
different fluorophores. In this case, you can incubate same
samples with both primary antibodies at the same time. In the
secondary antibody treatment, you should also add both sec-
ondary antibodies to the same well. While imaging, you can
take merged images showing expression of both proteins.
6. You can also use DAPI or some other fluorescent dyes com-
mercially available for nuclear staining. However, check
whether the excitation and emission wavelengths are suitable
with your fluorescent/confocal microscope before carrying out
staining.
7. Brain lysate preparation: We prepare lysate from frozen (stored
at 80 C) mouse brain. It can also be prepared from fresh
tissue. Mince brain with scalpel after weighing. Add 1 mL of
urea buffer to 1 g tissue, and sonicate with a probe sonicator on
ice. Incubate at 95–100 C for 5–10 min. Determine the total
protein concentration by a method of your choice (we use
Bradford method).
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